NAT10 and cancer: To investigate NAT10-regulated miRNA downstream targets which drive cancer progression, RNA-Seq was conducted in A549 cells with stable knockdown of NAT10 to identify the mRNA transcript expression profile affected by NAT10 (Supplementary Table S10).